Open AccessCost per number needed to treat and treatment cost of baricitinib versus adalimumab on rheumatoid arthritis treatment in the brazilian private healthcare system
Author(s) -
Bruno Corona Prandi,
Mariana P Rosim,
Gabriel Ogata Pedro,
M. Papadimitropoulos
Publication year - 2023
Publication title -
jornal de assistência farmacêutica e farmacoeconomia
Language(s) - English
Resource type - Journals
ISSN - 2525-7323
DOI - 10.22563/2525-7323.2019.v4.s1.p.117
Subject(s) - medicine , adalimumab , rheumatoid arthritis , methotrexate , population , rheumatology , number needed to treat , arthritis , physical therapy , relative risk , confidence interval , environmental health